Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Characterization and Titration of an HIV Type 1 Subtype E Chimpanzee Challenge Stock
1997 StandoutNobel
Syndemics and the biosocial conception of health
2017 Standout
Particulate air pollution and acute health effects
1995 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Hepatitis B Virus Infection: Epidemiology and Vaccination
2006 Standout
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
2016
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy
2001
Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation
2005
The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world
2000
Hepatitis B virus infection
2009 Standout
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Hepatitis B vaccines
2003
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation
2002
Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection
2002
Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide
1995
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Transferred Herpes Simplex Virus Immunity after Stem‐Cell Transplantation: Clinical Implications
2003
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
HBsAg variants: Diagnostic-escape and diagnostic dilemma
2012
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
2000
Chronic hepatitis B
2007 Standout
IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection
1992
Chronic hepatitis B: Update 2009 #
2009 Standout
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
2003
HIV as the cause of AIDS
1996 StandoutNobel
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection
2007
HIV diversity, molecular epidemiology, and the role of recombination
2005
Evolution of the mammary gland from the innate immune system?
2006 StandoutNobel
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy
2005
Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology
1997 StandoutNobel
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation
2002
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1
1994
Human Parvovirus B19
2002 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2013
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
2006
Pathogenesis of human immunodeficiency virus infection
1993
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
A long-term follow-up study on hepatitis B surface antigen–positive patients undergoing allogeneic hematopoietic stem cell transplantation
2005
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues
2006
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
1993
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
1994 Standout
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
The anti-inflammatory effect of exercise
2005 Standout
Works of Wei Ling Lim being referenced
Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major.
1993
The Lack of Epidemiological Link between the HIV Type 1 Infections in Hong Kong and Mainland China
2004
The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers
2003
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
1998
Clearance of Persistent Hepatitis B Virus Infection in Chinese Bone Marrow Transplant Recipients Whose Donors Were Anti–Hepatitis B Core– and Anti–Hepatitis B Surface Antibody–Positive
1998
Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon‐treated patient
2001
Parvovirus B19 infection in Hong Kong
1997
A case-controlled study on the use of HBsAg-positive donors for allogeneic hematopoietic cell transplantation
2000
In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants.
1989
A case-controlled study on the use of HBsAg-positive donors for allogeneic hematopoietic cell transplantation
2000